Lovenox is called Clexane in Europe.
Information about Lovenox (Enoxaparin)
Lovenox is a low molecular weight heparin (LMWH) used as an anticoagulant to prevent and treat certain blood clots. It helps lower the risk of complications associated with thromboembolic disorders.
Product Highlights
- Prevention of deep vein thrombosis (DVT) in patients undergoing surgery or those with limited mobility.
- Care for DVT and pulmonary embolism (PE).
- Prevention of complications in individuals with acute coronary syndrome (ACS).
Key Ingredient
Key Benefits
- Lowers the risk of thromboembolic events, including DVT and PE.
- Easier to administer than unfractionated heparin, often requiring less frequent dosing.
- Has a predictable pharmacokinetic profile, allowing for fixed dosing without routine monitoring.
Direction of Use
- Administer Lovenox as directed by your healthcare provider, typically by subcutaneous injection.
- Inject into the fatty tissue of the abdomen or thigh, as instructed.
- Rotate injection sites to minimize irritation.
- Refrain from rubbing the injection site after administration.
Safety Concerns
- Common side effects may include bleeding, bruising at the injection site, and allergic reactions.
- Monitor for signs of unusual bleeding, such as blood in urine or stool.
- Regular blood tests may be required to monitor coagulation levels in some patients.
Avoid Lovenox (Enoxaparin) If
- You are allergic to enoxaparin or any other ingredients in the formulation.
- You have active bleeding or severe bleeding disorders.
- You have a previous history of heparin-induced thrombocytopenia (HIT).
- You are undergoing certain surgical procedures without adequate medical supervision.
- You are pregnant or breastfeeding without consulting a healthcare provider first.